Comparison of the effects of predilution and postdilution hemodiafiltration on neutrophils, lymphocytes and platelets

Journal of Artificial Organs

Volumn 16, Issue 3, 2013, Pages 316-321

  Sakurai, Kenji ^a   Saito, Takeshi ^a   Yamauchi, Fumi ^a   Asahi, Daiki ^a   Hosoya, Hiromi ^a  

^a Hashimoto Clinic   (Japan)

Author keywords

Biocompatibility; Cytokine; Hemodiafiltration; Lymphocyte blastoid transformation; Postdilution HDF; Predilution HDF

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; THYMIDINE;

ADULT; AMINO ACID TRANSPORT; ARTICLE; BLOOD CELL; CELL DAMAGE; CELL FUNCTION; CLINICAL ARTICLE; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOCYTE; LYMPHOCYTE TRANSFORMATION; MALE; NEUTROPHIL; PHAGOCYTOSIS; PLATELET MICROPARTICLE; POSTDILUTION HEMODIAFILTRATION; PREDILUTION HEMODIAFILTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THERAPY EFFECT; THROMBOCYTE; TREATMENT OUTCOME;

ADULT; AGED; BLOOD PLATELETS; FEMALE; HEMODIAFILTRATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS;

EID: 84885419226     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-013-0698-0     Document Type: Article

References (25)

1. Arenholz P, Winkler RE, Ramlow W, Tiess W, Müller W. On-line hemodiafiltration with pre- and postdilution: a comparison of efficacy. Int J Artif Organs. 1997;20:81-90.
2. Arenholz P, Winkler RE, Michelsen A, Land DA, Bowry SK. Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta-microglobulin/albumin relationship. Clin Nephrol. 2004;62:21-8.
3. Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrol Dial Transp. 2000;15:49-54.
4. Pedrini LA, De Cristofaro V, Pagliari B, Samà F. Mixed predilution and postdilution online hemodiafiltration compared with the traditional infusion modes. Kidney Int. 2000;58:2155-65.
5. Pedrini LA, De Cristofaro V. On-line mixed hemodiafiltration with a feedback for ultrafiltration control: effect on middle-molecule removal. Kidney Int. 2003;64:1505-13.
6. Canaud B, Levesque R, Krieter D, Desmeules S, Chaiabi L, Moragues H, Morena M, Cristol JP. On-line hemodiafiltration as routine treatment of end-stage renal failure: why pre- or mixed dilution mode is necessary in on-line hemodiafiltration today? Blood Purif. 2004;22:40-8.
7. Feliciani A, Rive MA, Zerbi S, Ruggiero P, Cozzi G, Pedrini LA. New strategies in haemodiafiltration (HDF): prospective comparative analysis between on-line mixed HDF and mid-dilution HDF. Nephrol Dial Transp. 2007;22:1672-9.
8. Maduell F, Arias M, Vera M, Fontsere N, Blasco M, Barros X, Garro J, Elena M, Bergada E, Cases A, Bedini JL, Compistol JM. Mid-dilution hemodiafiltration: a comparison with pre- and postdilution modes using the same polyphenylene membrane. Blood Purif. 2009;28:268-74.
9. Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, Ledebo I, Vanholder R. Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transp. 2009;24:62-570.
10. Canaud B, Bragg-Gresham JL, Marshal MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DPPPS. Kidney Int. 2006;69:2087-93.
11. Panichi V, Rizza GM, Paoletti S, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antoneli A, Panicucci E, Tripepi G, Tetta C, Palla R. RISCAVID Study Group. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transp. 2008;23:2337-43.
12. Santoro A, Mancici E, Bolzani R, Boggi R, Cagnoli L, Francioso A, Fusaroli M, Piazza V, Rapanà R, Strippoli GF. The effectiveness of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis. 2008;52:507-17.
13. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol. 2009;4:1944-53.
14. Locatelli F, Altieri P, Andrulli S, Bolasco P, Sau G, Pedrini LA, Basile C, David S, Feriani M, Montagna G, Di Iorio BR, Memoli B, Cravero R, Battaglia G, Zoccali C. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol. 2010;21:1798-807.
15. Masakane I. Selection of dilutional method for on-line HDF, pre- or post-dilution. Blood Purif. 2004;22:49-54.
16. Savica V, Ciolino F, Monardo P, Mallamace A, Savica R, Santoro D, Bellinghieri G. Nutritional status in hemodialysis patients: options for on-line convective treatment. J Ren Nutr. 2006;16:237-40.
17. Oppenheim JJ, Schecter B. Lymphocyte transformation. In: Rose NR, Friedman H, editors. Manual of clinical immunology. 2nd ed. Washington, DC: American Society for Microbiology; 1980. p. 233-41.
18. Hasuike Y, Nonoguchi H, Ito K, Naka M, Kitamura R, Nanami M, Tokuyama M, Kida A, Otaki Y, Kuragano T, Nakanishi T. Interleukin-6 is a predictor of mortality in stable hemodialysis patients. Am J Nephrol. 2009;30:389-98.
19. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagai H. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis. 1998;31:93-100.
20. Pecoits-Fiho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transp. 2002;17:1684-8.
21. Beberashvili I, Sinuani I, Azar A, Yasur H, Shapiro G, Feldman L, Averbukh Z, Weissgarten J. IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:2253-63.
22. Papayianni A, Alexopoulos E, Giamalis P, Belechri AM, Koukoudis P, Memmos D. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transp. 2002;17:435-41.
23. Papagianni A, Dovas S, Bantis C, Belechri AM, Kalovoulos M, Dimitriadis C, Efstratiadis G, Alexopoulos E, Memmos D. Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients. Am J Nephrol. 2008;28:265-74.
24. Filipoulos V, Hadjiyannakos D, Metaxaki P, Sideris V, Takouli L, Anogiati A, Vlassopoulos D. Inflammation and oxidative stress in patients on hemodiafiltration. Am J Nephrol. 2008;28:949-57.
25. Nakamura M, Hosoya Y, Hirose D, Tao T, Suzuki K, Tsuchida K, Minakuchi J, Kawashima S. Effects of predilution HDF and postdilution HDF on proinflammatory cytokine production. Kidney Dial. 2007;64:103-7. (Japanese).